ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2116

Hospitalization Rates and Utilization Among Rheumatoid Arthritis Patients: A Population-Based Study from 1987 to 2012

C. John Michet III1, Katrina Strobova2, Sara J. Achenbach3, Cynthia S. Crowson4 and Eric L. Matteson5, 1Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN, 2Department of Medicine, Charles University, Prague, Czech Republic, 3Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 4Health Sciences Research, Mayo Clinic, Rochester, MN, 5Rheumatology, Mayo Clinic, Rochester, MN

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Health Care, morbidity and mortality and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: Health Services Research

Session Type: Abstract Submissions (ACR)

Background/Purpose

Patients with rheumatoid arthritis (RA) experience chronic management issues and are at risk for complex comorbidities. It is unknown, however, to what extent the complications of the disease may lead to hospitalization. The goal of this study is to discern whether patients with RA are at greater risk for all-cause hospitalizations when compared to the general population.

Methods

This retrospective, population-based cohort study utilized patients who were 18 years or older and diagnosed with RA (as defined by the 1987 ACR criteria) between 1/1/1980 and 12/31/2007, and a reference cohort of patients without RA matched on age, sex, and calendar year. Each patient’s medical record was examined for hospitalizations from 1987 through 2012. For this analysis, follow-up began with the latter of index date or 1/1/1987 and ended at the earlier of death, last follow-up or 12/31/2012. Discharge diagnoses were grouped together using the Clinical Classifications Software for ICD-9-CM from Healthcare Cost and Utilization Project. Data were analyzed using person-year methods and rate ratios comparing RA to non-RA.

Results

The 799 RA and 797 non-RA cohorts each consist of patients with a mean age of 56 years (68% female) and a mean follow-up of 12 years and 13 years respectively. The patients with RA had 2968 hospitalizations and the non-RA patients had 2069 hospitalizations. RA patients proved to be at greater risk for all causes of hospitalization (Table 1). Increased risk for all-cause hospitalizations for patients with RA also held true for both sexes and all age groups.

Two discharge diagnoses are of interest. First, hospitalization for depression is a greater risk for male patients with RA (23 hospitalizations) than for the general male population (3 hospitalizations) (Rate Ratio [RR] 7.16, 95% Confidence Interval [CI] 2.78, 30.67). Second, patients with RA are at greater risk of hospitalization for diabetes (31 hospitalizations) than patients without RA (13 hospitalizations) (RR 2.45, CI 1.34, 4.89). Female patients with RA are at a significantly increased risk of hospitalization for diabetes (16 hospitalizations) when compared to the general female population (6 hospitalizations) (RR 2.65, CI 1.14, 7.45). An increased risk of hospitalization for diabetes is especially true for all RA patients age 45-64 (22 hospitalizations) when compared to the general population (0 hospitalizations) (RR 44.76, CI 8.32, 45072.3).

Conclusion

In this first ever analysis of all-cause hospitalizations in a population-based cohort, patients with RA appear to be at greater risk for hospitalization than patients without RA. This risk is true for both sexes and all age groups. RA patients are also markedly more likely to be hospitalized for depression if they are male. Furthermore, hospitalization for diabetes is prevalent among patients with RA, especially among females and patients in the 45-64 age group.

RA Rate*

Non-RA Rate*

Rate Ratio

Confidence Interval

Overall

30.4

20.2

1.51

1.42, 1.59

Sex

Female

29.0

19.2

1.51

1.41, 1.62

Male

33.6

22.4

1.50

1.36, 1.65

Ages

18-44

12.4

8.6

1.44

1.14, 1.84

45-64

22.4

10.8

2.07

1.86, 2.32

65-84

41.1

28.1

1.46

1.36, 1.58

85+

70.3

55.6

1.26

1.09, 1.46

*Rate of hospitalizations per 100 person-years


Disclosure:

C. J. Michet III,
None;

K. Strobova,
None;

S. J. Achenbach,
None;

C. S. Crowson,
None;

E. L. Matteson,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hospitalization-rates-and-utilization-among-rheumatoid-arthritis-patients-a-population-based-study-from-1987-to-2012/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology